CIK 0001818382
- Non-accelerated filer
- Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851763759
- Phone
- +1 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 6,564 shares (option exercise)
- 4 Exercise or conversion Director acquired 114,420 shares (option exercise)
- 4 Exercise or conversion President, CEO and Director acquired 114,420 shares (option exercise)
- 4 Open-market sale President, CEO and Director sold 2,000,000 shares at $2.78 ($5,560,000)
- 4 Open-market sale Director sold 2,000,000 shares at $2.78 ($5,560,000)
- 4 Open-market sale President, CEO and Director sold 1,799,596 shares at an average $3.54 ($6,378,837)
- 4 Open-market sale Director sold 1,799,596 shares at an average $3.54 ($6,378,837)
- 4 Open-market sale 10% owner sold 1,799,596 shares at an average $3.54 ($6,378,837)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 12 · 235 filings